Is screening for Chlamydia trachomatis infection cost effective?

Genitourinary Medicine

Volumn 73, Issue 2, 1997, Pages 103-104

  Paavonen, Jorma ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; HUMAN; PRIORITY JOURNAL; SCREENING; SHORT SURVEY;

EID: 0030925418     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.2.103     Document Type: Short Survey

References (23)

1. Piot P, Islam MQ. Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control. Sex Trans Dis 1994;21:S7-S13.
2. Paukku M, Puolakkainen M, Apter D, Hirvonen S, Paavonen J. First void urine testing for Chlamydia trachomatis by polymerase chain reaction in asymptomatic women. Sex Transm Dis (in press).
3. Witkin SS. Immune pathogenesis of asymptomatic Chlamydia trachomatis infections in the female genital tract. Infect Dis Obstet Gynecol 1995;3:169-74.
4. Hakama M, Lehtinen M, Knekt P, Aromaa A, Leinikki P, Miettinen A, et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years follow-up. Am J Epidemiol 1993;137:166-70.
5. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kimbauer R, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996;312:537-9.
6. Paavonen J. Chlamydia and cancer. Proceedings of the Third Meeting of the European Society for Chlamydia Research, Chantilly, France 1996:167.
7. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
8. Genç M, Ruusuvaara L, Mårdh P-A. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 1993;270:2057-64.
9. Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilisation. N Engl J Med 1994;331:239-43.
10. Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, et al. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 1995;27:265-72.
11. Rosenberg MJ, Waugh MS. Doxycycline or ofloxacin for outpatient chlamydial pelvic inflammatory disease? A cost-benefit and cost-effectiveness analysis. Infect Dis Obstet Gynecol 1995;3:12-21.
12. Goldfarb JM, Austin C, Lisbona H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilisation. Obstet Gynecol 1996;87:18-21.
13. Robinson R. Cost-benefit analysis. BMJ 1993;307:924-6.
14. Robinson R. Economic evaluation and health care. What does it mean? BMJ 1993;307:670-3.
15. Genç M, Mårdh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124:1-7.
16. Marrazzo JM, Celum CL, Fine D, DeLisle S, Mesure DJ, Handsneid HH. Cost-effectiveness of selective vs universal screening for Chlamydia trachomatis infection in women attending family planning and STD clinics. In: Orfila J, Byrne GI, Chernesky MA, Grayston J, Jones RB, Ridgway GL, et al, eds. Chlamydial infections. Bologna: Societa Editrice Esculapio, 1994:63-6.
17. Paavonen J, Puolakkainen M, Paukku M, Simonen H. Cost-benefit analysis of screening for cervical Chlamydia infection in low prevalence population. Proceedings of the Third Meeting of the European Society for Chlamydia Research, Chantilly, France 1996:254.
18. Sackett DL, Haynes RB, Guyatt GH. Clinical epidemiology. A basic science for clinical medicine. Toronto: Little, Brown, 1991.
19. Quinn TC, Welsh L, Lentz A, Crotchfelt K, Zenilman J, Newhall J, et al. Diagnosis of Chlamydia trachomatis infection in urine les by Amplicor polymerase chain reaction in women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996;34:1401-6.
20. Lee HH, Chernesky MA, Schachter J, Burczak JD, Andrews WW, Muldoon S, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995;345:213-6.
21. Schachter J, Moncada J, Whidden R, Shaw H, Bolan G, Burczak JD, et al. Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women. J Infect Dis 1995;172:1411-4.
22. Ripa T, Bauman H-D. Public health care against C trachomatis, a case to win. The Swedish experience and model calculations. Eleventh Meeting on the International Society for STD Research, New Orleans, Louisiana, 27-30 August 1995. Abstract no 254.
23. Apter D. Incidence of Chlamydia genital infections in a Finnish student population. (Abstract 59.) Congress of the European Union for School and University Health and Medicine, York, UK, 1995.